Author

Laura R. Porterfield

Observed names: LAURA R. PORTERFIELD, Laura Polakowski, Laura Porterfield, Laura R Porterfield, Porterfield, Laura

Institution: The University of Texas Medical Branch at Galveston

Observed institutions: University of Maryland, Baltimore, Brigham and Women's Hospital, Emory University, Baylor College of Medicine, University of California San Diego, University of Illinois Chicago, National Institute of Allergy and Infectious Diseases, The University of Texas Medical Branch at Galveston

ORCID: 0000-0001-9144-144X

Observed ORCID: 0000-0001-9144-144X

OpenAlex ID: A5034759076

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine

2020 · Lindsey R. Baden, Hana M. El Sahly, et al. · New England Journal of Medicine · 10,241

Rapid decline in vaccine-boosted neutralizing antibodies against SARS-CoV-2 Omicron variant

2022 · Kirsten E. Lyke, Robert L. Atmar, et al. · Cell Reports Medicine · 165

Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trial

2023 · Angela R. Branche, Nadine G. Rouphael, et al. · Nature Medicine · 59

PDF

A Phase 3 Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of V116 in Pneumococcal Vaccine–Experienced Adults 50 Years of Age or Older (STRIDE-6)

2024 · Paul Scott, Miwa Haranaka, et al. · Clinical Infectious Diseases · 42

Immunogenicity of NVX-CoV2373 heterologous boost against SARS-CoV-2 variants

2023 · Kirsten E. Lyke, Robert L. Atmar, et al. · npj Vaccines · 33

PDF

SARS-CoV-2 Variant Vaccine Boosters Trial: Preliminary Analyses

2022 · Angela R. Branche, Nadine G. Rouphael, et al. · medRxiv · 26

PDF

Clinical and Demographic Factors Associated With COVID-19, Severe COVID-19, and SARS-CoV-2 Infection in Adults

2023 · Deborah A. Theodore, Angela R. Branche, et al. · JAMA Network Open · 24

PDF

Risk of COVID-19 after natural infection or vaccination

2023 · Anne-Marie Rick, Matthew B. Laurens, et al. · EBioMedicine · 21

PDF

The Expanding Scope of GLP-1 Receptor Agonists: Six Uses Beyond Diabetes

2025 · Kyle Sheth, Stephanie Kim, et al. · Current Atherosclerosis Reports · 20

Hormone exposure and venous thromboembolism in commercially insured women aged 50 to 64 years

2023 · Susan C. Weller, John W. Davis, et al. · Research and Practice in Thrombosis and Haemostasis · 19

Statin Use and the Risk of Venous Thromboembolism in Women Taking Hormone Therapy

2023 · John W. Davis, Susan C. Weller, et al. · JAMA Network Open · 17

PDF

Safety and Immunogenicity of Influenza A/H5N8 Virus Vaccine in Healthy Adults: Durability and Cross-reactivity of Antibody Responses

2023 · Kathleen M Neuzil, Evan J Anderson, et al. · Clinical Infectious Diseases · 16

Vaginal Vitamin E for Treatment of Genitourinary Syndrome of Menopause: A Systematic Review of Randomized Controlled Trials

2022 · Laura Porterfield, Nyajuok Wur, et al. · Journal of Menopausal Medicine · 16

Incidence of venous thrombotic events and events of special interest in a retrospective cohort of commercially insured US patients

2022 · Susan C. Weller, Laura Porterfield, et al. · BMJ Open · 15

PDF

Addressing Training Gaps: A Competency-Based, Telehealth Training Initiative for Community Health Workers

2023 · Laura Porterfield, Victoria Warren, et al. · Telemedicine Reports · 13

PDF

Changing Missions of Medical Schools and Trends in Medical Student Diversity

2023 · Kendall M. Campbell, Dmitry Tumin, et al. · Family Medicine · 10

PDF

Family Medicine Team Perspectives on Screening for Health-Related Social Needs

2024 · Laura Porterfield, Quratulanne H. Jan, et al. · The Journal of the American Board of Family Medicine · 9

Evaluating the Test-Negative Design for COVID-19 Vaccine Effectiveness Using Randomized Trial Data

2025 · Leah I. B. Andrews, M. Elizabeth Halloran, et al. · JAMA Network Open · 8

PDF

SARS-CoV-2 Viral Load in the Nasopharynx at Time of First Infection Among Unvaccinated Individuals

2024 · Leigh H. Fisher, Jia Jin Kee, et al. · JAMA Network Open · 8

Does hormone therapy exacerbate other venous thromboembolism risk factors?

2024 · Laura Porterfield, John W. Davis, et al. · Menopause The Journal of The North American Menopause Society · 7

Preparing Community Health Workers to Empower Latino(a)s With Diabetes: A Real-World Implementation Study

2024 · Laura Porterfield, Zuleica Santiago Delgado, et al. · The Science of Diabetes Self-Management and Care · 7

Determining call-to-entry rate and recruitment barriers in clinical studies for community clinics serving low-income populations: a cohort study

2023 · Elizabeth M Vaughan, Salim Virani, et al. · BMJ Open · 7

PDF

A community health worker led diabetes self-management education program: Reducing patient and system burden

2024 · Laura Porterfield, Xiaoying Yu, et al. · Journal of Diabetes and its Complications · 5

Text messaging intervention for Pap smear uptake: a single-institution study

2023 · Namita Bhardwaj, Andrew T. Herndon, et al. · mHealth · 5

PDF

Resident Self-assessment and Clinical Competency Committee Evaluations in Family Medicine: A Single-Institution Study

2023 · Namita Bhardwaj, Laura Porterfield, et al. · Family Medicine · 5

PDF

Works count: 60

Citation count: 10,830

H-index: 14

I10-index: 16